Applied Therapeutics, Inc. — Director's Dealing 2021

Jun 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2021-06-03

Reporting Person: Kanter Stacy J. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-03	Stock Option (Right to Buy)	$19.70	A	16500	Acquired	2031-06-02	Common Stock (16500)	Direct

Footnotes

F1: One-twelfth (1/12th) of the shares subject to the Option shall vest on July 3, 2021 and each month thereafter, subject to the Reporting Person continuing to provide services through each such date.